Low calorie cranberry juice lowers blood pressure in healthy adults

American Heart Association News Tip - Abstract 299

September 20, 2012 Categories: Scientific Conferences & Meetings
EMBARGOED UNTIL 4 pm ET, Thursday, September 20, 2012
WASHINGTON, DC, September 20, 2012 - Regularly drinking low-calorie cranberry juice may help get your blood pressure under control, according to new findings presented at the American Heart Association’s High Blood Pressure Research 2012 Scientific Sessions.
 
In a study that measured the effects of drinking low-calorie cranberry juice, participants drank either low-calorie juice or a placebo drink every day for eight weeks as part of a controlled diet.
 
Blood pressure was measured at the beginning, mid-point and end of the study. After eight weeks, blood pressure values had significantly dropped from an average of 121/73 mmHg to 118/70 mmHg for those drinking the low-calorie cranberry juice. The placebo group showed no change.
 
Researchers note that cranberry juice is rich in antioxidants — naturally occurring molecules in fruit, tea, wine and other foods — which have been associated with lower blood pressure in other studies.
 
The study was funded by Ocean Spray Cranberries, Inc.
 
Note: Scientific presentation is at 1:45 p.m. ET, Thursday, September 20, 2012. 
 
Author disclosures are on the abstracts.
 
For the latest heart and stroke news, follow us on twitter: @HeartNews.
 
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events.  The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.  
 
Addtional resources, including multimedia, are available in the right column.
 
For media inquiries: (214) 706-1173
Audrey Ward: (214) 706-1166; t-audrey.ward@heart.org
Darcy Spitz: (212) 878-5940; Darcy.Spitz@heart.org
Julie Del Barto (broadcast): (214) 706-1330; Julie.DelBarto@heart.org
For public inquiries: (800) AHA-USA1 (242-8721)